A

Adaptive Phage Therapeutics

72 employees

Adaptive Phage Therapeutics provides therapeutic services intended to treat multi-drug resistant pathogenic bacteria.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Pharmaceutical

Date founded

2016

Funding rounds raised

Total raised

$41M

from 5 investors over 5 rounds

A

Adaptive Phage Therapeutics raised $5M on October 4, 2022

Investors: Defense Health Agency

A

Adaptive Phage Therapeutics raised $20M on April 4, 2022

Investors: AMR Action Fund

A

Adaptive Phage Therapeutics raised $41M on May 11, 2021

Investors: Mayo Clinic, Center for Innovation

A

Adaptive Phage Therapeutics raised $6.2M on June 5, 2020

Investors: Mayo Clinic, Center for Innovation

A

Adaptive Phage Therapeutics raised $33M on January 8, 2020

Investors: united-states-department-of-defense

FAQ